What does Stevanato Group SpA do?

Jun 22 2025 06:42 PM IST
share
Share Via
Stevanato Group SpA is a mid-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $270 million and a net profit of $28 million. Key metrics include a P/E ratio of 47.00 and a market cap of approximately $6.58 billion.
Overview:
Stevanato Group SpA operates in the Pharmaceuticals & Biotechnology industry and is classified as a mid-cap company.

Financial Snapshot:
Most recent Net Sales: 270 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 28 Million (Quarterly Results - Mar 2025)
Market-cap: USD 6,576.86 Million (Mid Cap)

Key Metrics:
P/E: 47.00
Dividend Yield: 0.00%
Debt Equity: 0.21
Return on Equity: 9.05%
Price to Book: 4.30

Contact Details:
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News